The mooted EU ban on perfluoroalkyl and polyfluoroalkyls opens the door for companies to develop replacements and create new markets

Restructuring is needed to enable interdisciplinary research that links the health of humans, animals and ecosystems

Taken from the finance world, the idea is to support a more diverse spread of research projects, giving money to unorthodox ideas

Free-of-charge service helping Horizon Europe projects better exploit results and maximise impact is getting a €14M upgrade

Unusually, Cluster 4 is dominated by the private sector, which receives 43% of funding and represents 68% of participants

Here’s a list of funding opportunities in the EU, UK, Africa, Singapore, Israel, and the US

A primer on which countries are part of the EU programme—and who’s sitting it out—from the new edition of Horizon Europe: The Essential Guide

Discover the top-funded countries and organisations in this snapshot from the newest edition of Horizon Europe: the Essential Guide 

For the first time, China has overtaken Europe in drug discovery, industry research shows

Provisional agreement means R&I gets €25M more than the Commission proposed, but the budget will still be lower than in 2024